U.S. number of venture capital deals for neurology companies 2006-2023

Published by
Matej Mikulic,
Nov 9, 2024
In 2023, there were 59 therapeutic company venture capital deals in the neurology sector in the United States. This graph shows the total number of venture capital deals for neurology companies in the U.S. from 2006 to 2023. Within the given period, 2022 was the peak based on number of such deals.

Number of venture capital deals for neurology companies in the U.S. from 2006 to 2023

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2024

Region

United States

Survey time period

2006 to 2023

Supplementary notes

* Added from previous editions of the same report.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in Norway "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in Norway

Overview

5

Pharmaceutical revenue

5

Production and trade

4

R&D, patents and new products

4

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical and biotech M&A activitiesGlobal pharmaceutical industryM&As worldwideM&As in EuropeM&As in the United States
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.